Rhein: an anthraquinone that modulates superoxide anion production from human neutrophils

M. Mian, S. Brunelleschi, S. Tarli, A. Rubino, D. Benetti, R. Fantozzi, L. Zilletti

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Rhein (4,5‐dihydroxyanthraquinone‐2‐carboxylic acid), the active metabolite of diacetylrhein, which has been reported as an effective antirheumatic drug in man, inhibited superoxide anion production from human neutrophils challenged with N‐formylmethionyl‐leucyl‐phenylalanine (FMLP: IC50, 2 times 10−5M) and A23186 (IC50, 10−5M), but not with phorbol myristate acetate. In the same concentration range (10−6‐10−3M), the drug did not affect oxy‐radical production by a cell‐free hypoxanthine‐xanthine oxidase system and exerted weak inhibitory effects on FMLP‐evoked lysosomal enzyme release. Rhein inhibitory effects on neutrophil functioning may contribute to the overall therapeutic activity of the parent drug, diacetylrhein. 1987 Royal Pharmaceutical Society of Great Britain

Lingua originaleInglese
pagine (da-a)845-847
Numero di pagine3
RivistaJournal of Pharmacy and Pharmacology
Volume39
Numero di pubblicazione10
DOI
Stato di pubblicazionePubblicato - ott 1987
Pubblicato esternamente

Fingerprint

Entra nei temi di ricerca di 'Rhein: an anthraquinone that modulates superoxide anion production from human neutrophils'. Insieme formano una fingerprint unica.

Cita questo